|
Originally published In Press as doi:10.1074/jbc.M302492200 on April 30, 2003
J. Biol. Chem., Vol. 278, Issue 29, 26533-26540, July 18, 2003
Cyclic AMP-dependent Phosphorylation of Cyclin D3-bound CDK4 Determines the Passage through the Cell Cycle Restriction Point in Thyroid Epithelial Cells*
Sabine Paternot ,
Katia Coulonval ¶,
Jacques E. Dumont and
Pierre P. Roger ¶ ||
From the
Institute of Interdisciplinary Research
and ¶Protein Chemistry Department, Faculté
de Médecine, Université Libre de Bruxelles, Campus Erasme,
B-1070 Brussels, Belgium
According to current concepts, the cell cycle commitment after restriction
(R) point passage requires the sustained stimulation by mitogens of the
synthesis of labile D-type cyclins, which associate with
cyclin-dependent kinase (CDK) 4/6 to phosphorylate pRb family proteins and
sequester the CDK inhibitor p27kip1. In primary cultures of dog
thyroid epithelial cells, the cAMP-dependent cell cycle induced by a sustained
stimulation by thyrotropin or forskolin differs from growth factor mitogenic
pathways, as cAMP does not upregulate D-type cyclins but increases
p27 levels. Instead, cAMP induces the assembly of required cyclin D3-CDK4
complexes, which associate with nuclear p27. In this study, the arrest of
forskolin stimulation rapidly slowed down the entry of dog thyrocytes into S
phase and the phosphorylation of pRb family proteins. The pRb kinase activity,
but not the formation, of the cyclin D3-CDK4-p27 complex was strongly reduced.
Using two-dimensional gel electrophoresis, a phosphorylated form of CDK4 was
separated. It appeared in response to forskolin and was bound to both cyclin
D3 and p27, presumably reflecting the activating Thr-172 phosphorylation of
CDK4. Upon forskolin withdrawal or after cycloheximide addition, this CDK4
phosphoform unexpectedly persisted in p27 complexes devoid of cyclin D3 but it
disappeared from the more labile cyclin D3 complexes. These data demonstrate
that the assembly of the cyclin D3-CDK4-p27 holoenzyme and the subsequent
phosphorylation and activation of CDK4 depend on distinct cAMP actions. This
provides a first example of a crucial regulation of CDK4 phosphorylation by a
mitogenic cascade and a novel mechanism of cell cycle control at the R
point.
Received for publication, March 11, 2003
, and in revised form, April 25, 2003.
* This study was supported by grants from the National Fund for Scientific
Research (FNRS), the Belgian Fund for Scientific Medical Research (FRSM),
Télévie, and the Fortis Bank cancer research fund. The costs of
publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Fellow of the Fonds pour la Formation à la Recherche dans
l'Industrie et l'Agriculture (FRIA).
||
Research Associate of the FNRS. To whom correspondence should be addressed:
I.R.I.B.H.M., ULB, Campus Erasme, Bldg. C, 808 Route de Lennik, B-1070
Brussels, Belgium. Tel.: 322-555-4153; Fax: 322-555-4655; E-mail:
proger{at}ulb.ac.be.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Paternot and P. P. Roger
Combined Inhibition of MEK and Mammalian Target of Rapamycin Abolishes Phosphorylation of Cyclin-Dependent Kinase 4 in Glioblastoma Cell Lines and Prevents Their Proliferation
Cancer Res.,
June 1, 2009;
69(11):
4577 - 4581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ray, M. K. James, S. Larochelle, R. P. Fisher, and S. W. Blain
p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes
Mol. Cell. Biol.,
February 15, 2009;
29(4):
986 - 999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Rocha, S. Paternot, K. Coulonval, J. E. Dumont, P. Soares, and P. P. Roger
Cyclic AMP Inhibits the Proliferation of Thyroid Carcinoma Cell Lines through Regulation of CDK4 Phosphorylation
Mol. Biol. Cell,
November 1, 2008;
19(11):
4814 - 4825.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fukushima, T. Nedachi, H. Akizawa, M. Akahori, F. Hakuno, and S.-I. Takahashi
Distinct Modes of Activation of Phosphatidylinositol 3-Kinase in Response to Cyclic Adenosine 3', 5'-Monophosphate or Insulin-Like Growth Factor I Play Different Roles in Regulation of Cyclin D1 and p27Kip1 in FRTL-5 Cells
Endocrinology,
July 1, 2008;
149(7):
3729 - 3742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dony, Y-J. Lai, R. Dumitrascu, S. S. Pullamsetti, R. Savai, H. A. Ghofrani, N. Weissmann, C. Schudt, D. Flockerzi, W. Seeger, et al.
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition
Eur. Respir. J.,
March 1, 2008;
31(3):
599 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dremier, M. Milenkovic, S. Blancquaert, J. E. Dumont, S. O. Doskeland, C. Maenhaut, and P. P. Roger
Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Dependent Protein Kinases, But Not Exchange Proteins Directly Activated by cAMP (Epac), Mediate Thyrotropin/cAMP-Dependent Regulation of Thyroid Cells
Endocrinology,
October 1, 2007;
148(10):
4612 - 4622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Schermuly, S. S. Pullamsetti, G. Kwapiszewska, R. Dumitrascu, X. Tian, N. Weissmann, H. A. Ghofrani, C. Kaulen, T. Dunkern, C. Schudt, et al.
Phosphodiesterase 1 Upregulation in Pulmonary Arterial Hypertension: Target for Reverse-Remodeling Therapy
Circulation,
May 1, 2007;
115(17):
2331 - 2339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paternot, J. E. Dumont, and P. P. Roger
Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture
Mol. Endocrinol.,
December 1, 2006;
20(12):
3279 - 3292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bockstaele, H. Kooken, F. Libert, S. Paternot, J. E. Dumont, Y. de Launoit, P. P. Roger, and K. Coulonval
Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK "Inhibitors".
Mol. Cell. Biol.,
July 1, 2006;
26(13):
5070 - 5085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fortemaison, S. Blancquaert, J. E. Dumont, C. Maenhaut, K. Aktories, P. P. Roger, and S. Dremier
Differential Involvement of the Actin Cytoskeleton in Differentiation and Mitogenesis of Thyroid Cells: Inactivation of Rho Proteins Contributes to Cyclic Adenosine Monophosphate-Dependent Gene Expression but Prevents Mitogenesis
Endocrinology,
December 1, 2005;
146(12):
5485 - 5495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Mitsutake, J. A. Knauf, S. Mitsutake, C. Mesa Jr., L. Zhang, and J. A. Fagin
Conditional BRAFV600E Expression Induces DNA Synthesis, Apoptosis, Dedifferentiation, and Chromosomal Instability in Thyroid PCCL3 Cells
Cancer Res.,
March 15, 2005;
65(6):
2465 - 2473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vitagliano, F. Carlomagno, M. L. Motti, G. Viglietto, Y. E. Nikiforov, M. N. Nikiforova, J. M. Hershman, A. J. Ryan, A. Fusco, R. M. Melillo, et al.
Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells
Cancer Res.,
June 1, 2004;
64(11):
3823 - 3829.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|